Back

Great Debate: SGLT2 inhibitors should be first-line treatment in heart failure with reduced ejection fraction

European Heart Journal

28 May 2024
Organised by: Logo
Read full article
ESC Journals CARDIOVASCULAR PHARMACOLOGY HEART FAILURE Acute Heart Failure Chronic Heart Failure

Contributors

Milton Packer
Milton Packer

Author

Baylor University Medical Center Dallas , United States of America

John G F Cleland
John G F Cleland

Author

University of Glasgow Glasgow , United Kingdom of Great Britain & Northern Ireland

Johann Bauersachs
Johann Bauersachs

Author

Hannover Medical School Hannover , Germany

You may be interested in
thumbnail
Congress Session
No time like the present: heart failure in the hospital setting
30 August 2024
thumbnail
Congress Session
Meet the Experts: summation of the science - treatment of chronic heart failure in 2023
28 August 2023
thumbnail
Congress Presentation
Comparison between angiotensin receptor neprilysin inhibitor-first and sodium-glucose cotransporter 2 inhibitors-first strategies in patients with symptomatic heart failure and reduced ejection fracti
21 May 2023
thumbnail
Congress Session
Great Debate: controversies in the contemporary management of HFrEF
26 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources